Insider Transactions in Q2 2024 at Arcellx, Inc. (ACLX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
10,000
-74.86%
|
$540,000
$54.26 P/Share
|
|
Jun 27
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$60,000
$6.66 P/Share
|
|
Jun 26
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,877
-34.83%
|
$682,481
$53.97 P/Share
|
|
Jun 12
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,000
-34.45%
|
$1,100,000
$55.58 P/Share
|
|
Jun 12
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+30.36%
|
$200,000
$10.64 P/Share
|
|
May 24
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,121
-37.98%
|
$606,050
$50.71 P/Share
|
|
May 23
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,428
+41.27%
|
-
|
|
May 01
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
18,168
-21.21%
|
$944,736
$52.16 P/Share
|
|
May 01
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,168
+40.13%
|
$109,008
$6.28 P/Share
|
|
Apr 16
2024
|
Olivia C Ware |
SELL
Open market or private sale
|
Direct |
9,402
-86.11%
|
$517,110
$55.7 P/Share
|
|
Apr 16
2024
|
Olivia C Ware |
BUY
Exercise of conversion of derivative security
|
Direct |
9,402
+50.0%
|
$65,814
$7.61 P/Share
|
|
Apr 01
2024
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
23,086
-8.99%
|
$1,546,762
$67.56 P/Share
|